1239462-41-9 Usage
Description
3-(trifluoromethyl)quinolin-5-amine is a chemical compound with the molecular formula C10H7F3N2, belonging to the quinoline derivatives. It features a trifluoromethyl group at the 3-position and an amine group at the 5-position on the quinoline ring. 3-(trifluoromethyl)quinolin-5-amine is known for its potential applications in medicinal chemistry, particularly in the development of pharmaceuticals and agrochemicals, due to its unique structure and properties.
Uses
Used in Pharmaceutical Development:
3-(trifluoromethyl)quinolin-5-amine is used as a building block for the synthesis of novel compounds with potential biological activity. Its unique structure allows for the creation of new pharmaceuticals that may have therapeutic effects in various medical conditions.
Used in Agrochemical Development:
In the agrochemical industry, 3-(trifluoromethyl)quinolin-5-amine is used as a precursor for the development of new compounds with potential applications in crop protection. Its unique properties may contribute to the creation of effective and environmentally friendly agrochemicals.
Further research and exploration of 3-(trifluoromethyl)quinolin-5-amine's uses may lead to new discoveries in drug development and crop protection, expanding its applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1239462-41-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,4,6 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1239462-41:
(9*1)+(8*2)+(7*3)+(6*9)+(5*4)+(4*6)+(3*2)+(2*4)+(1*1)=159
159 % 10 = 9
So 1239462-41-9 is a valid CAS Registry Number.
1239462-41-9Relevant articles and documents
INHIBITORS OF JUN N-TERMINAL KINASE
-
Page/Page column 148, (2010/08/18)
The present disclosure provides inhibitors of c-Jun N-terminal kinases (JNK) having a structure according to the following formula (I): or a salt or solvate thereof, wherein ring A, Ca, Cb, Z, R5, W and Cy are defined herein. The disclosure further provides pharmaceutical compositions including the compounds of the present disclosure and methods of making and using the compounds and compositions of the present disclosure, e.g., in the treatment and prevention of various disorders, such as Alzheimer's disease.
